Chaeum Premium No. 2 Regulatory Status: A Professional Guide for Market Access

Chaeum Premium No. 2 is a hyaluronic acid (HA) dermal filler developed by Hugel, a prominent South Korean biopharmaceutical company. As a professional-grade injectable, its formulation is intended for specific aesthetic indications, aligning with the standards expected of HA fillers. For clinics assessing their product range, understanding the origin and manufacturer's background is a foundational step in evaluating product suitability and reliability. Further options for hyaluronic acid fillers are available in our HA filler catalog.

Regulatory compliance is non-negotiable for medical aesthetic products. For Chaeum Premium No. 2, like other Korean-manufactured fillers, the primary domestic approval comes from the Ministry of Food and Drug Safety (MFDS) in South Korea, formerly known as KFDA. This body ensures manufacturing quality and product safety within its jurisdiction. Additionally, manufacturers often pursue other certifications:

• GMP (Good Manufacturing Practices): Hugel adheres to stringent GMP standards, ensuring consistent quality and control in manufacturing processes.
• ISO 13485: This international standard specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements. [VERIFY: ISO 13485 certification for Chaeum Premium No. 2 specific production line]
• CE Mark: [VERIFY: CE Mark status for Chaeum Premium No. 2 for European Union market access]. Many South Korean fillers, such as Elasty Plus 1CC, seek CE marking to facilitate broader international distribution.
• FDA (USA): [VERIFY: FDA approval status for Chaeum Premium No. 2]. Direct FDA approval for specific Korean dermal fillers is less common without targeted market strategy.

The legal status of Chaeum Premium No. 2 varies by region, depending on specific country-level medical device regulations. Professionals must verify local import and distribution requirements for their respective markets:

• European Union (EU) & United Kingdom (UK): Market entry typically requires CE Mark certification, indicating compliance with EU health, safety, and environmental protection standards. Post-Brexit, the UK largely mirrors EU regulations but has its own evolving framework.
• GCC (Gulf Cooperation Council): Countries like UAE and Saudi Arabia have their own health authorities (e.g., MOHAP, SFDA) that require product registration and authorization. Documentation of origin, quality certifications, and authorized distributor agreements are usually mandatory.
• LATAM (Latin America): Regulations vary significantly by country (e.g., ANVISA in Brazil, COFEPRIS in Mexico). Local registrations, often supported by international certifications, are common.
• APAC (Asia-Pacific): Beyond South Korea, market access depends on each country’s national regulatory body (e.g., HSA in Singapore, TGA in Australia). Local registrations are standard.

While attractive for perceived cost savings, sourcing Chaeum Premium No. 2 through parallel import channels carries inherent risks for professional practices. Products obtained via unauthorized routes may lack verifiable cold chain integrity, come without proper batch documentation, or even be counterfeit. Such practices can compromise product safety and efficacy, leading to professional and ethical liabilities. We recommend understanding supplier credentials, as discussed in our guide on COLENA Regulatory Status: Understanding Market Access for Pr.

To ensure legitimate and compliant sourcing of Chaeum Premium No. 2, professionals should demand comprehensive documentation from their wholesale supplier. Key documents include:

• Certificate of Authenticity/Origin: Verifies the product's legitimate manufacturing source.
• Batch Release Certificate: Confirms quality control testing for specific batches.
• Valid Regulatory Certificates: Copies of MFDS, CE Mark (if applicable), or other relevant regional approvals.
• Cold Chain Declaration: Proof of proper temperature-controlled transport, crucial for HA filler stability, similar to considerations for products like D.Fill Medium.
• Authorized Distributor Letters: If applicable, proof of the supplier's authorization by Hugel for specific markets.

For professionals looking to stock Chaeum Premium No. 2, selecting a reputable wholesale distributor is paramount. A reliable partner will offer transparent documentation, guaranteed cold chain logistics, and competitive pricing based on volume. Indicative wholesale pricing for Chaeum Premium No. 2, for example, might start at $86.8 per unit, with volume tiers offering additional percentage discounts (e.g., 11 units → 4% off, 21 units → 5% off, 31 units → 6% off, 51+ units → 8% off). Prioritizing suppliers who verify authenticity and adhere to strict handling protocols, as outlined in guides like Yvoire Volume Plus: Professional Handling and Storage Guide, safeguards your practice and patients.